Everis

Everis is a medical device company based in Schoolcraft, Michigan, founded in early 2019. The company focuses on acquiring, investing in, and revitalizing products to enhance their global impact, particularly in head and neck surgery. Everis rebranded from C2Dx in May 2025 to reflect its growth and commitment to advancing healthcare technologies through strategic partnerships. The company offers a range of clinically proven medical devices designed for head and neck surgery, including the Shaw Scalpel®, Biodesign® grafts, and sialendoscopy instruments. These products support minimally invasive procedures, natural healing, and diagnostics. Everis emphasizes superior customer service and continuous evolution to meet the needs of healthcare providers, aiming for exceptional patient outcomes. The company is led by CEO Kevin McLeod and VP of Marketing Sarah Hollingsworth, and it has recently partnered with Southmedic Incorporated for Canadian distribution of its ENT portfolio.